What is Essex Bio-Technology Price-to-Operating-Cash-Flow?
As of today (2025-05-31), Essex Bio-Technology's share price is HK$5.22.
Essex Bio-Technology's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.64. Hence, Essex Bio-Technology's Price-to-Operating-Cash-Flow Ratio for today is 8.21.
The historical rank and industry rank for Essex Bio-Technology's Price-to-Operating-Cash-Flow or its related term are showing as below:
HKSE:01061'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 3.41 Med: 13.44 Max: 82.26
Current: 8.21
During the past 13 years, Essex Bio-Technology's highest Price-to-Operating-Cash-Flow Ratio was 82.26. The lowest was 3.41. And the median was 13.44.
Essex Bio-Technology's Cash Flow from Operations per share for the
six
months ended in Dec. 2024 was HK$0.41.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.64.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Essex Bio-Technology was 11.20% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -2.40% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 8.40% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 24.10% per year.
During the past 13 years, Essex Bio-Technology's highest 3-Year average Operating Cash Flow per Share Growth Rate was 119.00% per year. The lowest was -22.20% per year. And the median was 23.70% per year.
Essex Bio-Technology Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Essex Bio-Technology's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Essex Bio-Technology Price-to-Operating-Cash-Flow Chart
|
Essex Bio-Technology Annual Data
|
|
Trend |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
Dec24 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
8.27 |
7.28 |
6.57 |
4.38 |
4.64 |
|
Essex Bio-Technology Semi-Annual Data
|
|
Jun15 |
Dec15 |
Jun16 |
Dec16 |
Jun17 |
Dec17 |
Jun18 |
Dec18 |
Jun19 |
Dec19 |
Jun20 |
Dec20 |
Jun21 |
Dec21 |
Jun22 |
Dec22 |
Jun23 |
Dec23 |
Jun24 |
Dec24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
6.57 |
- |
4.38 |
- |
4.64 |
Competitive Comparison of Essex Bio-Technology's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Essex Bio-Technology's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Essex Bio-Technology's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Essex Bio-Technology's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Essex Bio-Technology's Price-to-Operating-Cash-Flow falls into.
Essex Bio-Technology Price-to-Operating-Cash-Flow Calculation
Essex Bio-Technology's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 5.22 | / | 0.636 |
| = | 8.21 |
Essex Bio-Technology's Share Price of today is HK$5.22.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Essex Bio-Technology's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.64.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Essex Bio-Technology Business Description
Traded in Other Exchanges
N/A
Address
No. 88, Keji 6th Road, Hi-Tech Zone, Guangdong, Zhuhai, CHN
Essex Bio-Technology Ltd is principally engaged in investment holding and development, manufacture and sale of biologic drugs in the People's Republic of China. The company is made up of segments of Ophthalmology products and Surgical products. Its products under Ophthalmology include the Beifushu series, Tobramycin Eye Drops, Levofloxacin Eye Drops, Sodium Hyaluronate Eye Drops. The products under Surgical include the Beifuji series, Carisolv dental caries removal gel and mouth wash. The majority of the groups revenue comes from PRC.
Executives
Essex Bio-Technology Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01061 has been successfully added to your